{"id":"W2036287069","doi":"10.1016/j.ygyno.2013.05.008","title":"Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Hamilton Health Sciences; Juravinski Cancer Centre; Queen's University; Cancer Care Ontario; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Temsirolimus; Cervix; Oncology; Internal medicine; Clinical trial; Gynecology; Phases of clinical research; Cancer; Discovery and development of mTOR inhibitors","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004537671,0.0003532659,0.003124736,0.0002457342,0.00009482408,0.000005510453,0.0006091898,0.0002766808,0.001132006],"category_scores_gemma":[0.009688561,0.0001500618,0.0003253713,0.001748332,0.0005044166,0.00008338073,0.0003783792,0.000618099,0.000004956019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005518206,"about_ca_system_score_gemma":0.001222971,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009004959,"about_ca_topic_score_gemma":0.002781764,"domain_scores_codex":[0.9908761,0.004530992,0.002828974,0.0005612733,0.0006138083,0.0005888077],"domain_scores_gemma":[0.9888073,0.007765585,0.002090035,0.0008417701,0.0002952242,0.0002001184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4971863,0.08090696,0.05076823,0.0003405571,0.001394381,0.00009147649,0.001959287,0.00003970884,0.001049905,0.00004737405,0.0001823814,0.3660334],"study_design_scores_gemma":[0.4323666,0.316052,0.2458522,0.0001046968,0.0009297326,0.00001617005,0.003214273,0.00003552243,0.0002466434,0.0004666988,0.0005509314,0.0001645446],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871278,0.0002728058,0.000004925329,0.000456504,0.001108346,0.01032984,0.00003771583,0.00001426165,0.0006477761],"genre_scores_gemma":[0.9971949,0.0001066557,0.0002046371,0.000361253,0.000125232,0.001765829,0.000005846799,0.00002368936,0.0002119464],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3658689,"threshold_uncertainty_score":0.9997811,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1296047535755556,"score_gpt":0.4369952286122137,"score_spread":0.3073904750366581,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}